155 related articles for article (PubMed ID: 26281768)
1. Theoretical considerations for thresholds in chemical carcinogenesis.
Thomas AD; Fahrer J; Johnson GE; Kaina B
Mutat Res Rev Mutat Res; 2015; 765():56-67. PubMed ID: 26281768
[TBL] [Abstract][Full Text] [Related]
2. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
[TBL] [Abstract][Full Text] [Related]
3. Low doses and thresholds in genotoxicity: from theories to experiments.
Zito R
J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
[TBL] [Abstract][Full Text] [Related]
4. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
[TBL] [Abstract][Full Text] [Related]
5. Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents.
Klapacz J; Pottenger LH; Engelward BP; Heinen CD; Johnson GE; Clewell RA; Carmichael PL; Adeleye Y; Andersen ME
Mutat Res Rev Mutat Res; 2016; 767():77-91. PubMed ID: 27036068
[TBL] [Abstract][Full Text] [Related]
6. Genotoxic thresholds, DNA repair, and susceptibility in human populations.
Jenkins GJ; Zaïr Z; Johnson GE; Doak SH
Toxicology; 2010 Dec; 278(3):305-10. PubMed ID: 19932733
[TBL] [Abstract][Full Text] [Related]
7. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
Snow ET; Sykora P; Durham TR; Klein CB
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
[TBL] [Abstract][Full Text] [Related]
8. [Theory and practice of primary cancer prevention].
Tompa A
Magy Onkol; 2007; 51(1):7-21. PubMed ID: 17417671
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
10. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro.
Clewell RA; Andersen ME
Mutagenesis; 2016 May; 31(3):333-40. PubMed ID: 26846943
[TBL] [Abstract][Full Text] [Related]
11. [Role of DNA repair in chemical carcinogenesis].
Likhachev AIa
Vopr Onkol; 1987; 33(1):3-11. PubMed ID: 3544490
[No Abstract] [Full Text] [Related]
12. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships in chemical carcinogenesis: from DNA adducts to tumor incidence.
Lutz WK
Adv Exp Med Biol; 1991; 283():151-6. PubMed ID: 2068982
[TBL] [Abstract][Full Text] [Related]
14. Formation, detection, and role in carcinogenesis of ethenobases in DNA.
Bartsch H; Barbin A; Marion MJ; Nair J; Guichard Y
Drug Metab Rev; 1994; 26(1-2):349-71. PubMed ID: 8082574
[No Abstract] [Full Text] [Related]
15. Epigenetic mechanisms of chemical carcinogenesis.
Klaunig JE; Kamendulis LM; Xu Y
Hum Exp Toxicol; 2000 Oct; 19(10):543-55. PubMed ID: 11211991
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility differences in chemical carcinogenesis linearize the dose-response relationship: threshold doses can be defined only for individuals.
Lutz WK
Mutat Res; 2001 Oct; 482(1-2):71-6. PubMed ID: 11535250
[TBL] [Abstract][Full Text] [Related]
17. Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing.
Guérard M; Baum M; Bitsch A; Eisenbrand G; Elhajouji A; Epe B; Habermeyer M; Kaina B; Martus HJ; Pfuhler S; Schmitz C; Sutter A; Thomas AD; Ziemann C; Froetschl R
Mutat Res Rev Mutat Res; 2015; 763():181-201. PubMed ID: 25795120
[TBL] [Abstract][Full Text] [Related]
18. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
Bolt HM; Degen GH
Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes.
Lutz WK
Mutat Res; 1998 Sep; 405(2):117-24. PubMed ID: 9748532
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of carcinogenesis: the role of systems of DNA repair].
Moustacchi E
Bull Acad Natl Med; 1998; 182(1):33-46; discussion 47. PubMed ID: 9622930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
